← The SEC Ephemeris: the whole map
Nobelpharma Co., Ltd. sirolimus
In the graph: all 1 documents (3 pages).
- Application
- NDA 213478
- Ticker
- Nobelpharma Co., Ltd.
- Product
- sirolimus
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- August 13, 2020
From FDA letters and SEC filings. Not investment or medical advice.